78451-11-3

Usage

Uses

Used in Pharmaceutical Industry:
Ethyl 2-chloro-4-methyl-5-oxazolecarboxylate is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
ethyl 2-chloro-4-Methyloxazole-5-carboxylate is utilized as an intermediate in the production of agrochemicals, specifically insecticides, fungicides, and herbicides. Its presence in these products contributes to their effectiveness in controlling pests and diseases in agriculture.
Used in Organic Synthesis:
Ethyl 2-chloro-4-methyl-5-oxazolecarboxylate serves as a building block in organic synthesis, enabling the creation of a wide range of chemical compounds for various applications. Its functional groups facilitate its involvement in numerous chemical reactions, making it a valuable component in the synthesis of diverse molecules.

Upstream product

• 540-80-7 tert.-butylnitrite 
• 79221-15-1 ethyl 2-amino-4-methyl-1,3-oxazole-5-carboxylate 
• 609-15-4 ethyl 2-chloro-3-oxo-butyrate 
• 141-97-9 ethyl acetoacetate 

Relevant academic research and scientific papers

THERAPEUTIC INHIBITORY COMPOUNDS

Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for inhibiting plasma kallikrein. Furthermore, the subject compounds and compositions are useful for the treatment of diseases

SUBSTITUTED INDAZOLE COMPOUNDS AS IRAK4 INHIBITORS

The present invention provides substituted indazole compound of formula (I) and pharmaceutically acceptable salts thereof, and their use to inhibit IRAK4 and/or for the treatment of diseases or disorders induced by IRAK4.

PYRROLE CARBOXYLIC ACID DERIVATIVES AS ANTIBACTERIAL AGENTS

The present invention provides DNA Gyrase and/or Topo IV inhibitors of Formula (I), which can be used as antibacterial agents. Compounds disclosed herein can be used for treating or preventing conditions caused by or contributed by gram positive, gram negative and anaerobic bacteria, more particularly against, for example, Staphylococci, Streptococci, Enterococci, Haemophilus, Pseudomonus spp., Acenetobacter spp., Mvraxalla spp., Chlamydia spp., Mycoplasma spp., Legionella spp., Mycobacterium spp., Helicobacter, Clostridium spp., Bacteroides spp., Cotynebacterium, Bacillus spp., Enterobactericeae (E. coli, Klebsiella spp., Proteus spp., etc.) or any combination thereof. Also provided, are processes for preparing compounds disclosed herein, pharmaceutical compositions containing compounds disclosed herein, and methods of treating bacterial infections.

PYRROLE CARBOXYLIC ACID DERIVATIVES AS ANTIBACTERIAL AGENTS

The present invention provides DNA Gyrase and/or Topo IV inhibitors of formula I, which can be used as antibacterial agents. Compounds disclosed herein can be used for treating or preventing conditions caused by or contributed by gram positive, gram negative and anaerobic bacteria, more particularly against, for example, Staphylococci, Streptococci, Enterococci, Haemophilus, Pseudomonus spp., Acenetobacter spp., Muraxalla spp., Chlamydia spp., Mycoplasma spp., Legionella spp., Mycobacterium spp., Helicobacter, Clostridium spp., Bacteroides spp., Cotyne bacterium, Bacillus spp., Enterobactericeae (E.coli, Klebsiella spp., Proteus spp.,etc.) or any combination thereof Also provided, are processes for preparing compounds disclosed herein, pharmaceutical compositions containing compounds disclosed herein, and methods of treating bacterial infections

2-Substituted-4-alkyl or trihaloalkyl-5-oxazolecarboxylic acids as safening agents

Derivatives of 2-substituted-4-alkyl or trihaloalkyl-5-oxazolecarboxylic acid have been found to be effective in reducing herbicidal injury to crop plants caused by thiocarbamate and acetanilide herbicides, and especially in reducing herbicidal injury to rice, sorghum or wheat crops, especially rice and sorghum, caused by triallate, alachlor and butachlor herbicides.